Device Trial Radar · NCT03295682
Registry in Patients With Thoracoabdominal Aneurysms
Last checked: Nov 20, 2026Latest source record: Feb 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
47
Actual
Start
Sep 11, 2017
Primary completion
May 31, 2022
Study completion Aug 30, 2024
Sponsor
- Lead sponsor
- JOTEC GmbHNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 28, 2017
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In this study patients will be observed, who receive a multi-branch stent graft tailored to the patients anatomy for the endovascular treatment of a thoracoabdominal aortic aneurysm Crawford type I, II, III, IV or V. The objective of this study is to evaluate clinical and technical success as well as safety and feasibility of the multi-branch stent graft Systems used in endovascular treatment of thoracoabdominal aortic aneurysms that cannot be treated with commercially available devices. Primary endpoint of this study is the rate of patients with stable or decreasing aneurysm size at 12 months follow-up.
Conditions
- Thoracoabdominal Aneurysm
Interventions
Endovascular thoracoabdominal aneurysm repairDevice
Endovascular treatment of patients with thoracoabdominal aneurysm using a multibranch stent graft tailored to the patient´s anatomy in combination with peripheral covered stents to bridge the visceral arteries
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of patients with stable or decreasing aneurysm size at 12 months follow-up (measured by CoreLab)Time frame: 12 months follow-up
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Uniklinikum Düsseldorf
Düsseldorf, North Rhine-Westphalia, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.